Related Experiment Video
Updated: Feb 10, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
3.3K
Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus
Pediatrics
|July 5, 2005
Insights
Diabetic retinopathy (DR) is a leading cause of blindness in young adults. Early screening and treatment for pediatric patients with type 1 diabetes can prevent vision loss.
Area of Science:
- Ophthalmology
- Endocrinology
- Pediatrics
Background:
- Diabetic retinopathy (DR) is the primary cause of vision loss in young adults in the U.S.
- Early detection and intervention are crucial for preventing irreversible vision impairment.
- Type 1 diabetes mellitus (T1DM) in pediatric populations requires specific management strategies to mitigate DR risks.
Purpose of the Study:
- To review the identified risk factors associated with the development of diabetic retinopathy in pediatric patients.
- To provide evidence-based screening guidelines for the early detection of DR in children and adolescents with T1DM.
Main Methods:
- Literature review of clinical reports and studies focusing on DR in pediatric T1DM.
- Analysis of risk factors contributing to DR onset and progression.
- Synthesis of current screening recommendations for pediatric DR.
Main Results:
- Identified key risk factors including glycemic control, duration of diabetes, and hypertension.
- Highlighted the importance of regular ophthalmological examinations starting at diagnosis or within 5 years.
- Emphasized tailored screening intervals based on individual risk profiles.
Conclusions:
- Prompt identification and management of DR risk factors are essential in pediatric T1DM.
- Adherence to recommended screening protocols can significantly reduce the incidence of vision loss.
- This review provides a framework for clinicians to optimize DR surveillance in young patients with diabetes.
Abstract:
Diabetic retinopathy (DR) is the leading cause of blindness in young adults in the United States. Early identification and treatment of DR can decrease the risk of vision loss in affected patients. This clinical report reviews the risk factors for the development of DR and screening guidance for pediatric patients with type 1 diabetes mellitus.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
330
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
330
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
307
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
307
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
245
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
274
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274
01:22Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K